Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
Q1 2026 earnings • released • EPS beat +25,90% • Revenue beat +11,25%
See results
LILY34:BVMF
Eli Lilly And Company BDR
R$154,50
+8,05%
(+11,51) 1D
30 Apr., 17:10:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for LILY34...
Open
R$152,04
High
R$156,30
Low
R$149,50
Mkt. cap
910,17 mjd
Avg. vol.
10,58 k
Volume
0,00
52-wk high
R$208,12
52-wk low
R$112,58
Shares outstanding
944,82 m
No. of employees
50 k
News stories
From sources across the web
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50 k
Founded1876
HeadquartersIndianapolis, Indiana, Verenigde State van Amerika
SectorPharmaceutical industry
Websitelilly.com
Last report
30 Apr. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
8,55/ (6,79 est.)USD
+25,90%beat
Revenue / Estimate
19,80 mjd/ (17,80 mjd est.)USD
+11,25%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
15,56 mjd
17,60 mjd
19,29 mjd
19,80 mjd
Cost of goods sold
2,45 mjd
3,01 mjd
3,37 mjd
3,58 mjd
Cost of revenue
2,45 mjd
3,01 mjd
3,37 mjd
3,58 mjd
Research and development expenses
3,34 mjd
3,47 mjd
3,80 mjd
3,51 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,65 mjd
2,63 mjd
3,46 mjd
2,93 mjd
Operating expense
5,98 mjd
6,09 mjd
7,26 mjd
6,44 mjd
Total operating expenses
8,43 mjd
9,10 mjd
10,63 mjd
10,02 mjd
Operating income
7,13 mjd
8,50 mjd
8,66 mjd
9,78 mjd
Other non operating income
-101,00 m
-9,10 m
181,20 m
109,00 m
EBT including unusual items
6,78 mjd
7,23 mjd
8,27 mjd
8,85 mjd
EBT excluding unusual items
6,82 mjd
8,21 mjd
8,89 mjd
9,63 mjd
Income tax expense
1,12 mjd
1,65 mjd
1,63 mjd
1,45 mjd
Effective tax rate
16,47%
22,81%
19,70%
16,43%
Other operating expenses
-
-
-
-
Net income
5,66 mjd
5,58 mjd
6,64 mjd
7,40 mjd
Net profit margin
36,38%
31,72%
34,41%
37,36%
Earnings per share
6,31
7,02
7,54
8,55
Interest and investment income
40,00 m
65,00 m
672,40 m
-
Interest expense
-249,00 m
-179,60 m
-153,30 m
-253,00 m
Net interest expenses
-209,00 m
-114,60 m
519,10 m
-253,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
7,60 mjd
8,97 mjd
9,25 mjd
10,28 mjd
Gain or loss from assets sale
-
-
-180,00 m
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer